Characterization of arrhythmia substrate to ablate persistent atrial fibrillation (COAST-AF): Randomized controlled trial design and rationale

Autor: Pablo B. Nery, George A. Wells, Atul Verma, Jacqueline Joza, Girish M. Nair, George Veenhuyzen, Jason Andrade, Isabelle Nault, Jorge A. Wong, Markus Sikkel, Vidal Essebag, Laurent Macle, John Sapp, Jean-Francois Roux, Allan Skanes, Paul Angaran, Paul Novak, Damian Redfearn, Mehrdad Golian, Calum J. Redpath, Marcio Sturmer, David Birnie
Rok vydání: 2022
Předmět:
Zdroj: American Heart Journal. 254:133-140
ISSN: 0002-8703
DOI: 10.1016/j.ahj.2022.08.010
Popis: Atrial low voltage area (LVA) catheter ablation has emerged as a promising strategy for ablation of persistent atrial fibrillation (AF). It is unclear if catheter ablation of atrial LVA increases treatment success rates in patients with persistent AF.The primary aim of this trial is to assess the potential benefit of adjunctive catheter ablation of atrial LVA in addition to pulmonary vein isolation (PVI) in patients with persistent AF, when compared to PVI alone. The secondary aims are to evaluate safety outcomes, the quality of life and the healthcare resource utilization.A multicenter, prospective, parallel-group, 2-arm, single-blinded randomized controlled trial is under way (NCT03347227). Patients who are candidates for catheter ablation for persistent AF will be randomly assigned (1:1) to either PVI alone or PVI + atrial LVA ablation. The primary outcome is 18-month documented event rate of atrial arrhythmia (AF, atrial tachycardia or atrial flutter) post catheter ablation. Secondary outcomes include procedure-related complications, freedom from atrial arrhythmia at 12 months, AF burden, need for emergency department visits/hospitalization, need for repeat ablation for atrial arrhythmia, quality of life at 12 and 18 months, ablation time, and procedure duration.Characterization of Arrhythmia Mechanism to Ablate Atrial Fibrillation (COAST-AF) is a multicenter randomized trial evaluating ablation strategies for catheter ablation. We hypothesize that catheter ablation of atrial LVA in addition to PVI will result in higher procedural success rates when compared to PVI alone in patients with persistent AF.
Databáze: OpenAIRE
Externí odkaz: